TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Uscom Limited ( (AU:UCM) ) has issued an update.
Uscom Limited announced a change in the director’s interest, with Robert Allan Phillips converting 9,670,117 performance rights into ordinary shares, increasing his total holdings to 93,958,881 shares. This conversion, approved at the 2024 AGM, reflects a strategic move to align the director’s interests with the company’s growth, potentially impacting stakeholder confidence and market perception positively.
More about Uscom Limited
Uscom Limited operates in the medical technology industry, focusing on the development and distribution of non-invasive cardiovascular and pulmonary medical devices. The company aims to provide innovative solutions for the diagnosis and management of heart and lung diseases, targeting healthcare providers and patients globally.
Average Trading Volume: 280,019
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$4.01M
Find detailed analytics on UCM stock on TipRanks’ Stock Analysis page.